JPRN-UMIN000034640已完成未知
The effect of sucroferric oxyhydroxide starting from a small amount - The effect of sucroferric oxyhydroxide starting from a small amount
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients complicated with serious diseases such as cancer, hematological disorders, and liver cirrhosis
研究者
相似试验
已完成
不适用
Study of the efficacy of sucroferric oxyhydroxide (chewable tablet) on the control of CKD-MBD and improvement of renal anemia in hemodialysis patients with hyperphosphatemia.Hyperphosphatemia in chronic kidney disease patients on hemodialysisJPRN-UMIN000023657Kawashima Hospital, Social Medical Corporation Kawashima Hospital Group50
已完成
不适用
Efficacy and safety of sucroferric oxyhydroxide on hemodialysis patientsChronic kidney diseaseJPRN-UMIN000032867Department of Nephrology, hypertension and Endocrinology, Nihon University School of Medicine60
已完成
不适用
Effect of Intravenous Saccharated Ferric Oxide on Serum FGF23 and Mineral Metabolism in Hemodialysis PatientsHemodialysis patients with iron-deficiency anemiaJPRN-UMIN000004814kobe university school of medicine, division of nephrology and kidney center30
已完成
不适用
Sucroferric oxyhydroxide Guanules Questionnaire surveyImprovement of hyperphosphatemia in dialysis patientsJPRN-UMIN000034904Qol Co.,Ltd.75
进行中（未招募）
1 期
A Study to Investigate the Effect of ß-Hydroxy-ß-Methylbutyrate (HMB) on Skeletal Muscle Wasting in Early Critical Illness.Critical illnessMedDRA version: 20.0Level: PTClassification code 10077264Term: Critical illnessSystem Organ Class: 10018065 - General disorders and administration site conditionsEUCTR2016-003557-15-GBGuy's and St Thomas NHS Foundation Trust68